Heidelberg Pharma AG

XTRA:HPHA Stok Raporu

Piyasa değeri: €121.2m

Heidelberg Pharma Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Andreas Pahl

İcra Kurulu Başkanı

€450.7k

Toplam tazminat

CEO maaş yüzdesi53.3%
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresi1.7yrs
Yönetim Kurulu ortalama görev süresi12.5yrs

Son yönetim güncellemeleri

Recent updates

Is Heidelberg Pharma (ETR:HPHA) A Risky Investment?

Feb 16
Is Heidelberg Pharma (ETR:HPHA) A Risky Investment?

Heidelberg Pharma AG's (ETR:HPHA) Price In Tune With Revenues

Dec 05
Heidelberg Pharma AG's (ETR:HPHA) Price In Tune With Revenues

Industry Analysts Just Upgraded Their Heidelberg Pharma AG (ETR:HPHA) Revenue Forecasts By 21%

Jul 21
Industry Analysts Just Upgraded Their Heidelberg Pharma AG (ETR:HPHA) Revenue Forecasts By 21%

Analyst Forecasts For Heidelberg Pharma AG (ETR:HPHA) Are Surging Higher

Oct 16
Analyst Forecasts For Heidelberg Pharma AG (ETR:HPHA) Are Surging Higher

Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely

Nov 28
Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely

Heidelberg Pharma AG (ETR:HPHA) Analysts Are More Bearish Than They Used To Be

Mar 27
Heidelberg Pharma AG (ETR:HPHA) Analysts Are More Bearish Than They Used To Be

We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Mar 15
We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Investors Who Bought Heidelberg Pharma (ETR:HPHA) Shares Five Years Ago Are Now Up 245%

Jan 17
Investors Who Bought Heidelberg Pharma (ETR:HPHA) Shares Five Years Ago Are Now Up 245%

We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Dec 14
We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

CEO Tazminat Analizi

Andreas Pahl'un ücretlendirmesi Heidelberg Pharma'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Aug 31 2024n/an/a

-€19m

May 31 2024n/an/a

-€13m

Feb 29 2024n/an/a

-€18m

Nov 30 2023€451k€240k

-€20m

Aug 31 2023n/an/a

-€22m

May 31 2023n/an/a

-€27m

Feb 28 2023n/an/a

-€19m

Nov 30 2022€328k€240k

-€20m

Aug 31 2022n/an/a

-€21m

May 31 2022n/an/a

-€22m

Feb 28 2022n/an/a

-€27m

Nov 30 2021€442k€240k

-€26m

Aug 31 2021n/an/a

-€25m

May 31 2021n/an/a

-€22m

Feb 28 2021n/an/a

-€20m

Nov 30 2020€295k€207k

-€18m

Aug 31 2020n/an/a

-€17m

May 31 2020n/an/a

-€15m

Feb 29 2020n/an/a

-€12m

Nov 30 2019€288k€200k

-€10m

Aug 31 2019n/an/a

-€10m

May 31 2019n/an/a

-€11m

Feb 28 2019n/an/a

-€12m

Nov 30 2018€286k€200k

-€12m

Aug 31 2018n/an/a

-€11m

May 31 2018n/an/a

-€11m

Feb 28 2018n/an/a

-€11m

Nov 30 2017€241k€171k

-€11m

Tazminat ve Piyasa: Andreas's total compensation ($USD491.78K) is about average for companies of similar size in the German market ($USD488.36K).

Tazminat ve Kazançlar: Andreas's compensation has increased whilst the company is unprofitable.

CEO

Andreas Pahl

less than a year

Görev süresi

€450,663

Tazminat

Prof. Dr. Andreas Pahl is Chief Executive Officer & Spokesman of the Executive Board at Heidelberg Pharma AG since February 1, 2024 and had been its Chief Scientific Officer and Member of the Executive Man...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Andreas Pahl
CEO & Spokesman of the Executive Boardless than a year€450.66kVeri yok
Walter Miller
Chief Financial Officer1.5yrs€398.63kVeri yok
Jorg Kemkowski
Chief Operating Officer1.8yrsVeri yokVeri yok
Sylvia Wimmer
Director Corporate Communicationno dataVeri yokVeri yok
Andras Strassz
Chief Medical Officer3.7yrsVeri yokVeri yok
George Badescu
Chief Business Officerno dataVeri yokVeri yok

1.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim: HPHA's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Friedrich von Bohlen und Halbach
Member of the Supervisory Board19.6yrs€18.00kVeri yok
Georg Baur
Deputy Chairman of the Supervisory Board24.8yrs€38.00kVeri yok
Christof Hettich
Chairman of Supervisory Board14.5yrs€49.50kVeri yok
Birgit Kudlek
Member of the Supervisory Board12.5yrs€21.75kVeri yok
Mathias Hothum
Deputy Chairman of Supervisory Board9.3yrs€39.00kVeri yok
Dongzhou Liu
Member of Supervisory Board2.4yrs€21.00kVeri yok
Yan Xia
Member of Supervisory Board1.5yrs€9.96kVeri yok

12.5yrs

Ortalama Görev Süresi

59.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: HPHA's board of directors are seasoned and experienced ( 12.5 years average tenure).